Zacks: Analysts Expect electroCore, Inc. (NASDAQ:ECOR) to Announce -$0.08 Earnings Per Share

Brokerages expect that electroCore, Inc. (NASDAQ:ECORGet Rating) will post earnings of ($0.08) per share for the current quarter, according to Zacks Investment Research. Two analysts have provided estimates for electroCore’s earnings. electroCore reported earnings of ($0.09) per share during the same quarter last year, which indicates a positive year over year growth rate of 11.1%. The company is scheduled to issue its next quarterly earnings report on Monday, January 1st.

According to Zacks, analysts expect that electroCore will report full-year earnings of ($0.29) per share for the current financial year, with EPS estimates ranging from ($0.30) to ($0.28). For the next year, analysts expect that the firm will report earnings of ($0.23) per share, with EPS estimates ranging from ($0.25) to ($0.21). Zacks’ EPS calculations are a mean average based on a survey of sell-side analysts that cover electroCore.

electroCore (NASDAQ:ECORGet Rating) last released its earnings results on Thursday, May 5th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by ($0.03). electroCore had a negative return on equity of 56.15% and a negative net margin of 283.37%. During the same period in the prior year, the business posted ($0.11) EPS.

Separately, Maxim Group initiated coverage on electroCore in a research note on Friday, March 11th. They issued a “buy” rating and a $1.50 price objective on the stock.

A number of large investors have recently added to or reduced their stakes in ECOR. UBS Group AG grew its position in shares of electroCore by 222.6% in the third quarter. UBS Group AG now owns 25,598 shares of the company’s stock valued at $29,000 after purchasing an additional 17,662 shares during the last quarter. Jane Street Group LLC acquired a new position in shares of electroCore in the third quarter valued at approximately $31,000. SWM Advisors acquired a new position in shares of electroCore in the fourth quarter valued at approximately $38,000. Eidelman Virant Capital grew its position in shares of electroCore by 680.0% in the fourth quarter. Eidelman Virant Capital now owns 78,000 shares of the company’s stock valued at $46,000 after purchasing an additional 68,000 shares during the last quarter. Finally, Virtu Financial LLC acquired a new position in shares of electroCore in the first quarter valued at approximately $53,000. Hedge funds and other institutional investors own 18.91% of the company’s stock.

NASDAQ:ECOR traded up $0.02 on Monday, hitting $0.43. The company’s stock had a trading volume of 3,036 shares, compared to its average volume of 1,471,717. The stock has a fifty day moving average of $0.47 and a two-hundred day moving average of $0.59. The firm has a market capitalization of $30.43 million, a P/E ratio of -1.59 and a beta of 1.04. electroCore has a one year low of $0.27 and a one year high of $1.85.

About electroCore (Get Rating)

electroCore, Inc, a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults.

Read More

Get a free copy of the Zacks research report on electroCore (ECOR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for electroCore Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for electroCore and related companies with MarketBeat.com's FREE daily email newsletter.